| | |
Radhieka Pandeya and C.H. Unnikrishnan 10:05 PM | September 30,2009
The Israeli firm lawsuit in the US against Sun says it failed to disclose FDA’s seizure of Caraco products, closure of operations
|
|
PTI 01:56 PM | September 20,2009
The company would file these applications along with its US-based subsidiary Caraco, which is facing trouble due to non-compliance of current good manufacturing practice of the US drug regulator
|
|
02:16 PM | August 03,2009
Under the settlement agreement, MedImmune would grant a licence to Sun Pharma for certain patents, permitting the company to continue marketing the generic version of Ethyol in the US
|
|
Reuters 05:52 PM | July 29,2009
Sun Pharma’s rival drugmaker Cipla posted a 73% jump in April-June net profit
|
|
PTI 11:47 AM | June 01,2009
Sun Pharmaceutical chairman Dilip Shanghvi said if we are able to get all the shares of Taro Pharmaceuticals including promoters shares then the total cost would be up to Rs1,000 crore
|
|
Radhieka Pandeya 10:00 PM | May 07,2009
According to Justia, the amount demanded by the plaintiff (Wyeth) from the defendant (Sun) is $75,000
|
|
PTI 02:06 PM | April 13,2009
The tablets are in the strength of 5mg, 15mg and 30mg and is used as a narcotic painkiller in the treatment of moderate to severe pain
|
|
Radhieka Pandeya and C.H. Unnikrishnan 12:22 AM | February 28,2009
India’s drug industry is concerned this could mean slower drug approvals for other pharma companies
|
|
C.H. Unnikrishnan 12:20 AM | January 30,2009
Examiners have been asked to state the type of objections raised, the firms’ explanations and reasons for waiving objections
|
|
Bhuma Shrivastava 11:56 PM | November 04,2008
The US food and drug administration, however, has not blocked Sun Pharma’s exports into the US or asked for mass withdrawal of medicines
|
|
12:03 AM | September 04,2008
The car maker is concerned about the quality gap that exists between the best and the worst supplier
|
|
C.H. Unnikrishnan 10:31 PM | August 28,2008
The Israeli court allowed India’s biggest drug maker to go ahead with a tender offer for all the shares of the Israeli company, but Sun Pharma had already waived some conditions so its offer could be closed on 3 September
|
|
C.H. Unnikrishnan 11:02 PM | July 16,2008
Sun Pharma, which currently holds around 36% of Taro, had on 30 June commenced the open offer for Taro shares in the US following the Israeli company’s decision to terminate a merger agreement that it had signed with the Indian firm a year ago
|
|
C.H. Unnikrishnan 12:59 AM | May 31,2008
Sun Pharma, India’s biggest drug maker by market value, posted a net profit of Rs1,486.9 crore, compared with Rs784.27 crore the previous fiscal year. Sales rose 57% to Rs3,501 crore
|
|